Contact Us
Close
Enter your
text here

Our Edge

The Excelra Edge comes from a seamless amalgamation of data, deep domain expertise and data science.

Transforming Life Science Data into Actionable Insights

DATA SCIENCE
+
DOMAIN
+
DATA

Data Science

Validated AI/ML pipelines including Deep Learning

Proprietary text mining and NLP algorithms

Big data and high throughput cloud computing

Domain

Multidisciplinary blend of Math, Computation and Life Sciences

Rich and diverse experience across various therapeutic areas

Scientists from top universities with publications in leading journals

Data

6M+ man-hours of curated data from Discovery to Real World

4 proprietary data platforms and integration of 40+ public databases

Scalable multilingual techno-human curation engine

previous arrowprevious arrow
next arrownext arrow
Slider

Transforming Life Science
Data into Actionable Insights

Data Science

Validated AI/ML pipelines including Deep Learning

Proprietary text mining and NLP algorithms

Big data and high throughput cloud computing

Domain

Multidisciplinary blend of Math, Computation and Life Sciences

Rich and diverse experience across various therapeutic areas

Scientists from top universities with publications in leading journals

Data

6M+ man-hours of curated data from Discovery to Real World

4 proprietary data platforms and integration of 40+ public databases

Scalable multilingual techno-human curation engine

previous arrowprevious arrow
next arrownext arrow
Slider
icon

18+

Years Experience

icon

15 of 20

Top Pharma

icon

90+

Clients Globally

icon

60+

PhDs

icon

600+

Talent Pool

Every aspect of the pharmaceutical value-chain involves generation of voluminous data. Excelra turns these vast data-pools into meaningful insights that unlock operational efficiencies, and increase the speed and accuracy of drug discovery, clinical development, regulatory approval, reimbursement, and market access.

The life sciences industry is at the cusp of a data science revolution. We help our partners adapt their business model to the new digital reality and become future ready. Being an end-to-end solution provider, we break down silos, integrate data and analytics across omics, clinical trials, and RWE to uncover novel insights and opportunities.